I cannot find anything that's not true. It certainly looks like something may be going on. It says that 20,000 of the 12 strikes were purchased AFTER the judge made her ruling. That would have had to be a new position since it looks like there were only 22,000+ traded for the expiration. In other words that position was initiated and not closed out. The same would apply to the 30,000 13's. If this works out someone is going to make a fortune! A two cent investment turned into an $88 dollar profit x 2 million shares! And that's at the $100 buyout. They paid much more for Lipitor 10 years ago. ($90 billion) If they pay $100 a share for Vascepa it would only be half!